CN117800977A - Preparation method and application of 2, 3-condensed quinazolinone compound - Google Patents
Preparation method and application of 2, 3-condensed quinazolinone compound Download PDFInfo
- Publication number
- CN117800977A CN117800977A CN202311796863.XA CN202311796863A CN117800977A CN 117800977 A CN117800977 A CN 117800977A CN 202311796863 A CN202311796863 A CN 202311796863A CN 117800977 A CN117800977 A CN 117800977A
- Authority
- CN
- China
- Prior art keywords
- mmol
- dichloromethane
- compound
- reaction
- water bath
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- -1 quinazolinone compound Chemical class 0.000 title claims description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 55
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 5
- GZKMGAXTHYGXEO-UHFFFAOYSA-M ruthenium(1+);triphenylphosphane;chloride Chemical compound [Ru]Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 GZKMGAXTHYGXEO-UHFFFAOYSA-M 0.000 claims description 18
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 claims description 14
- SBNOTUDDIXOFSN-UHFFFAOYSA-N 1h-indole-2-carbaldehyde Chemical compound C1=CC=C2NC(C=O)=CC2=C1 SBNOTUDDIXOFSN-UHFFFAOYSA-N 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 3
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims description 2
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- 125000001246 bromo group Chemical group Br* 0.000 claims 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims 4
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- YDFGUFMCWYGPJV-UHFFFAOYSA-N 2-amino-n-(3-hydroxypropyl)benzamide Chemical compound NC1=CC=CC=C1C(=O)NCCCO YDFGUFMCWYGPJV-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- VYFOAVADNIHPTR-UHFFFAOYSA-N isatoic anhydride Chemical compound NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 claims 1
- JVJQPDTXIALXOG-UHFFFAOYSA-N nitryl fluoride Chemical compound [O-][N+](F)=O JVJQPDTXIALXOG-UHFFFAOYSA-N 0.000 claims 1
- ACVGWSKVRYFWRP-UHFFFAOYSA-N Rutecarpine Chemical compound C1=CC=C2C(=O)N(CCC=3C4=CC=CC=C4NC=33)C3=NC2=C1 ACVGWSKVRYFWRP-UHFFFAOYSA-N 0.000 abstract description 18
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract description 18
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 10
- BCPAKGGXGLGKIO-UHFFFAOYSA-N Pseudorutaecarpin Natural products C1=CC=C2C(=O)N(CCC3=C4C5=CC=CC=C5N3)C4=NC2=C1 BCPAKGGXGLGKIO-UHFFFAOYSA-N 0.000 abstract description 9
- 229960000905 indomethacin Drugs 0.000 abstract description 9
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 231100000053 low toxicity Toxicity 0.000 abstract description 4
- 230000001472 cytotoxic effect Effects 0.000 abstract description 3
- 239000002552 dosage form Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 105
- 238000006243 chemical reaction Methods 0.000 description 86
- 239000005457 ice water Substances 0.000 description 70
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 69
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 67
- 239000012043 crude product Substances 0.000 description 58
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 57
- 239000003480 eluent Substances 0.000 description 57
- 238000010898 silica gel chromatography Methods 0.000 description 57
- 239000000843 powder Substances 0.000 description 53
- 238000003756 stirring Methods 0.000 description 52
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 44
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 36
- 238000007789 sealing Methods 0.000 description 27
- 238000003786 synthesis reaction Methods 0.000 description 26
- 230000015572 biosynthetic process Effects 0.000 description 24
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 23
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 23
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 23
- 229910000024 caesium carbonate Inorganic materials 0.000 description 23
- 239000003208 petroleum Substances 0.000 description 23
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 23
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 23
- 229910052757 nitrogen Inorganic materials 0.000 description 21
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 229910052707 ruthenium Inorganic materials 0.000 description 6
- RDVITFLODRVHRO-UHFFFAOYSA-N Cl.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound Cl.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1 RDVITFLODRVHRO-UHFFFAOYSA-N 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- IEHXXJMABHGXCG-UHFFFAOYSA-N 5-methoxy-1h-indole-2-carbaldehyde Chemical compound COC1=CC=C2NC(C=O)=CC2=C1 IEHXXJMABHGXCG-UHFFFAOYSA-N 0.000 description 3
- GSSNKPINGXEIFI-UHFFFAOYSA-N 6-chloro-1h-indole-2-carbaldehyde Chemical compound ClC1=CC=C2C=C(C=O)NC2=C1 GSSNKPINGXEIFI-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 2
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 2
- ASQOQJYHIYYTEJ-GBESFXJTSA-N (1r,7s,9as)-7-decyl-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-1-ol Chemical compound O[C@@H]1CCCN2C[C@@H](CCCCCCCCCC)CC[C@H]21 ASQOQJYHIYYTEJ-GBESFXJTSA-N 0.000 description 2
- KRIWIRSMQRQYJG-DLBZAZTESA-N (2s,3s)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol Chemical compound C=1C(N[C@@H](CO)[C@H](O)CO)=NC2=C(C(C)C)C=NN2C=1NCC1=CC=CC=C1 KRIWIRSMQRQYJG-DLBZAZTESA-N 0.000 description 2
- PHDIJLFSKNMCMI-ITGJKDDRSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)-4-(8-quinolin-6-yloxyoctoxy)oxane-2,3,5-triol Chemical compound OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)OCCCCCCCCOC=1C=C2C=CC=NC2=CC=1)O PHDIJLFSKNMCMI-ITGJKDDRSA-N 0.000 description 2
- LPNRUMVKXCLEBE-JXVRESAISA-L (3r)-4-[[(e)-2-[5-ethyl-4-(4-fluorophenyl)-6-phenyl-2-propan-2-ylpyridin-3-yl]ethenyl]-oxidophosphoryl]-3-hydroxybutanoate Chemical compound CCC1=C(C=2C=CC=CC=2)N=C(C(C)C)C(\C=C\P([O-])(=O)C[C@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 LPNRUMVKXCLEBE-JXVRESAISA-L 0.000 description 2
- QVBVQHTXLPNXEY-ZMFCMNQTSA-N (4r)-6-[2-[4-(4-fluorophenyl)-6-phenyl-2-propan-2-ylpyridin-3-yl]ethyl]-4-hydroxyoxan-2-one Chemical compound C([C@H](O)C1)C(=O)OC1CCC=1C(C(C)C)=NC(C=2C=CC=CC=2)=CC=1C1=CC=C(F)C=C1 QVBVQHTXLPNXEY-ZMFCMNQTSA-N 0.000 description 2
- MNIPVWXWSPXERA-IDNZQHFXSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecanoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)CCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 MNIPVWXWSPXERA-IDNZQHFXSA-N 0.000 description 2
- QOLHWXNSCZGWHK-BWBORTOCSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecylcarbamoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)NCCCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 QOLHWXNSCZGWHK-BWBORTOCSA-N 0.000 description 2
- JNPGUXGVLNJQSQ-BGGMYYEUSA-M (e,3r,5s)-7-[4-(4-fluorophenyl)-1,2-di(propan-2-yl)pyrrol-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CC(C)N1C(C(C)C)=C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)C(C=2C=CC(F)=CC=2)=C1 JNPGUXGVLNJQSQ-BGGMYYEUSA-M 0.000 description 2
- VAVHMEQFYYBAPR-ITWZMISCSA-N (e,3r,5s)-7-[4-(4-fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyhept-6-enoic acid Chemical compound CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(C=2C=CC(F)=CC=2)=CN1C1=CC=CC=C1 VAVHMEQFYYBAPR-ITWZMISCSA-N 0.000 description 2
- BOOYHBPHFVNWNH-OAHLLOKOSA-N 1-tert-butyl-6-[[(1R)-1-(4-chlorophenyl)ethyl]amino]-5-[(4-fluorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C[C@H](C1=CC=C(C=C1)Cl)NC2=NC3=C(C=NN3C(C)(C)C)C(=O)N2CC4=CC=C(C=C4)F BOOYHBPHFVNWNH-OAHLLOKOSA-N 0.000 description 2
- TXJUTRJFNRYTHH-UHFFFAOYSA-N 1h-3,1-benzoxazine-2,4-dione Chemical compound C1=CC=C2C(=O)OC(=O)NC2=C1 TXJUTRJFNRYTHH-UHFFFAOYSA-N 0.000 description 2
- YLLRPQWLASQXSI-UHFFFAOYSA-N 3-(4b,8a,9,9a-tetrahydro-4aH-pyrido[2,3-b]indol-4-ylamino)phenol Chemical compound Oc1cccc(NC2=CC=NC3NC4C=CC=CC4C23)c1 YLLRPQWLASQXSI-UHFFFAOYSA-N 0.000 description 2
- HZYLVYNCWLAIGF-UHFFFAOYSA-N 4-[[[2-(cyclohexylamino)-2-oxoethyl]-(4-propan-2-ylbenzoyl)amino]methyl]-N-hydroxybenzamide Chemical compound CC(C)c1ccc(cc1)C(=O)N(CC(=O)NC1CCCCC1)Cc1ccc(cc1)C(=O)NO HZYLVYNCWLAIGF-UHFFFAOYSA-N 0.000 description 2
- MWVKLRSIDOXBSE-UHFFFAOYSA-N 5-(1-piperidin-4-ylpyrazol-4-yl)-3-(6-pyrrolidin-1-yl-1,3-benzoxazol-2-yl)pyridin-2-amine Chemical compound NC1=NC=C(C2=CN(N=C2)C2CCNCC2)C=C1C(OC1=C2)=NC1=CC=C2N1CCCC1 MWVKLRSIDOXBSE-UHFFFAOYSA-N 0.000 description 2
- HIHOEGPXVVKJPP-JTQLQIEISA-N 5-fluoro-2-[[(1s)-1-(5-fluoropyridin-2-yl)ethyl]amino]-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile Chemical compound N([C@@H](C)C=1N=CC(F)=CC=1)C(C(=CC=1F)C#N)=NC=1NC=1C=C(C)NN=1 HIHOEGPXVVKJPP-JTQLQIEISA-N 0.000 description 2
- ZNQPHKBPSUZRAA-UHFFFAOYSA-N 5-methyl-1h-indole-2-carbaldehyde Chemical compound CC1=CC=C2NC(C=O)=CC2=C1 ZNQPHKBPSUZRAA-UHFFFAOYSA-N 0.000 description 2
- VCUKKMIXURRDKL-UHFFFAOYSA-N 9-(dimethylamino)-3-(4-ethylphenyl)pyrido[1,2]thieno[3,4-d]pyrimidin-4-one Chemical compound C1=CC(CC)=CC=C1N1C(=O)C(SC=2C3=C(N(C)C)C=CN=2)=C3N=C1 VCUKKMIXURRDKL-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- DGJMHKMYSDYOFP-MRXNPFEDSA-N C=CC(N(CCC1)C[C@@H]1N1N=C(C2=CN(CC(C3=CC=CC=C3)(F)F)N=N2)C2=C(N)N=CN=C12)=O Chemical compound C=CC(N(CCC1)C[C@@H]1N1N=C(C2=CN(CC(C3=CC=CC=C3)(F)F)N=N2)C2=C(N)N=CN=C12)=O DGJMHKMYSDYOFP-MRXNPFEDSA-N 0.000 description 2
- 229940126650 Compound 3f Drugs 0.000 description 2
- 229940126559 Compound 4e Drugs 0.000 description 2
- 229940125907 SJ995973 Drugs 0.000 description 2
- BEXZJJQVPWJPOA-VOTSOKGWSA-N [(e)-hept-2-enyl] 6-methyl-4-(4-nitrophenyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxylate Chemical compound CCCC\C=C\COC(=O)C1=C(C)NC(=O)NC1C1=CC=C([N+]([O-])=O)C=C1 BEXZJJQVPWJPOA-VOTSOKGWSA-N 0.000 description 2
- HGDWHTASNMRJMP-UHFFFAOYSA-N [1-(hydroxyamino)-1-oxo-5-(3-phenoxyphenyl)pentan-2-yl]phosphonic acid Chemical compound ONC(=O)C(P(O)(O)=O)CCCC1=CC=CC(OC=2C=CC=CC=2)=C1 HGDWHTASNMRJMP-UHFFFAOYSA-N 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- YBFBENHWPRGUMU-UHFFFAOYSA-N chembl398496 Chemical compound OC(=O)C1=CC=CC=C1NC(=O)N1CCN(C=2N=C3C=CC(O)=CC3=NC=2)CC1 YBFBENHWPRGUMU-UHFFFAOYSA-N 0.000 description 2
- 229940126115 compound 4f Drugs 0.000 description 2
- 229940125880 compound 4j Drugs 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 description 2
- JFOZKMSJYSPYLN-QHCPKHFHSA-N lifitegrast Chemical compound CS(=O)(=O)C1=CC=CC(C[C@H](NC(=O)C=2C(=C3CCN(CC3=CC=2Cl)C(=O)C=2C=C3OC=CC3=CC=2)Cl)C(O)=O)=C1 JFOZKMSJYSPYLN-QHCPKHFHSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 2
- XZMHJYWMCRQSSI-UHFFFAOYSA-N n-[5-[2-(3-acetylanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]benzamide Chemical compound CC(=O)C1=CC=CC(NC=2SC=C(N=2)C2=C(N=C(NC(=O)C=3C=CC=CC=3)S2)C)=C1 XZMHJYWMCRQSSI-UHFFFAOYSA-N 0.000 description 2
- RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical compound NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 2
- RTTUBUXMNUJHRR-DXRVJIQQSA-N (3s)-4-[[(e)-2-[1-(4-fluorophenyl)-3-propan-2-ylindol-2-yl]ethenyl]-hydroxyphosphoryl]-3-hydroxybutanoic acid Chemical compound C12=CC=CC=C2C(C(C)C)=C(\C=C\P(O)(=O)C[C@@H](O)CC(O)=O)N1C1=CC=C(F)C=C1 RTTUBUXMNUJHRR-DXRVJIQQSA-N 0.000 description 1
- PNHBRYIAJCYNDA-VQCQRNETSA-N (4r)-6-[2-[2-ethyl-4-(4-fluorophenyl)-6-phenylpyridin-3-yl]ethyl]-4-hydroxyoxan-2-one Chemical compound C([C@H](O)C1)C(=O)OC1CCC=1C(CC)=NC(C=2C=CC=CC=2)=CC=1C1=CC=C(F)C=C1 PNHBRYIAJCYNDA-VQCQRNETSA-N 0.000 description 1
- JWHYSEDOYMYMNM-QGZVFWFLSA-N 2-[4-[(2r)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid Chemical compound C([C@@H](OCC)CSC=1C=C(C)C(OCC(O)=O)=CC=1)OC1=CC=C(C(F)(F)F)C=C1 JWHYSEDOYMYMNM-QGZVFWFLSA-N 0.000 description 1
- QLVGHFBUSGYCCG-UHFFFAOYSA-N 2-amino-n-(1-cyano-2-phenylethyl)acetamide Chemical compound NCC(=O)NC(C#N)CC1=CC=CC=C1 QLVGHFBUSGYCCG-UHFFFAOYSA-N 0.000 description 1
- LIDUGWDLSDKCLM-CSKARUKUSA-N 4-[[3-[[[(e)-6,6-dimethylhept-2-en-4-ynyl]-ethylamino]methyl]phenoxy]methyl-dimethylsilyl]benzonitrile Chemical compound CC(C)(C)C#C/C=C/CN(CC)CC1=CC=CC(OC[Si](C)(C)C=2C=CC(=CC=2)C#N)=C1 LIDUGWDLSDKCLM-CSKARUKUSA-N 0.000 description 1
- BMUMJEKBMVREKT-UHFFFAOYSA-N 4-methoxy-1h-indole-2-carbaldehyde Chemical compound COC1=CC=CC2=C1C=C(C=O)N2 BMUMJEKBMVREKT-UHFFFAOYSA-N 0.000 description 1
- ZFWBIHAXMSSQOO-UHFFFAOYSA-N 5-chloro-1h-indole-2-carbaldehyde Chemical compound ClC1=CC=C2NC(C=O)=CC2=C1 ZFWBIHAXMSSQOO-UHFFFAOYSA-N 0.000 description 1
- KJBDXWPWJNDBOS-UHFFFAOYSA-N 5-methyl-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C2=C1C=CC=C2C KJBDXWPWJNDBOS-UHFFFAOYSA-N 0.000 description 1
- IGZHNWFLHSANSN-UHFFFAOYSA-N 6-bromo-1h-indole-2-carbaldehyde Chemical compound BrC1=CC=C2C=C(C=O)NC2=C1 IGZHNWFLHSANSN-UHFFFAOYSA-N 0.000 description 1
- MYQFJMYJVJRSGP-UHFFFAOYSA-N 6-chloro-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C2=CC(Cl)=CC=C21 MYQFJMYJVJRSGP-UHFFFAOYSA-N 0.000 description 1
- UBKGOWGNYKVYEF-UHFFFAOYSA-N 6-fluoro-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C2=CC(F)=CC=C21 UBKGOWGNYKVYEF-UHFFFAOYSA-N 0.000 description 1
- JFAFNQOODJCVGT-UHFFFAOYSA-N 6-methoxy-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C2=CC(OC)=CC=C21 JFAFNQOODJCVGT-UHFFFAOYSA-N 0.000 description 1
- AJVKTPKCOKFIAS-UHFFFAOYSA-N 7-(trifluoromethyl)-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C=2C1=CC(C(F)(F)F)=CC=2 AJVKTPKCOKFIAS-UHFFFAOYSA-N 0.000 description 1
- QRUPDIJQZCABTC-UHFFFAOYSA-N 7-chloro-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C=2C1=CC(Cl)=CC=2 QRUPDIJQZCABTC-UHFFFAOYSA-N 0.000 description 1
- XAJRDVIVFVGXNN-UHFFFAOYSA-N 7-methoxy-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C=2C1=CC(OC)=CC=2 XAJRDVIVFVGXNN-UHFFFAOYSA-N 0.000 description 1
- FTOHSJGKIFDLQU-UHFFFAOYSA-N 7-methyl-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C=2C1=CC(C)=CC=2 FTOHSJGKIFDLQU-UHFFFAOYSA-N 0.000 description 1
- ZPTOZGCACQWXJX-UHFFFAOYSA-N 8-methoxy-1h-3,1-benzoxazine-2,4-dione Chemical compound N1C(=O)OC(=O)C2=C1C(OC)=CC=C2 ZPTOZGCACQWXJX-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KGPGFQWBCSZGEL-ZDUSSCGKSA-N GSK690693 Chemical compound C=12N(CC)C(C=3C(=NON=3)N)=NC2=C(C#CC(C)(C)O)N=CC=1OC[C@H]1CCCNC1 KGPGFQWBCSZGEL-ZDUSSCGKSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- CDVMXMZPDJHSCC-UHFFFAOYSA-N chembl1684662 Chemical compound C=1C=C2C=C(C=3C4=NC=CC=C4NN=3)NC2=CC=1CC(=O)C1=CC=CC=C1 CDVMXMZPDJHSCC-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125796 compound 3d Drugs 0.000 description 1
- 229940125872 compound 4d Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- MUTCAPXLKRYEPR-ITWZMISCSA-N methyl (e,3r,5s)-7-[4-bromo-2,3-bis(4-fluorophenyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyhept-6-enoate Chemical compound COC(=O)C[C@H](O)C[C@H](O)\C=C\N1C(C(C)C)=C(Br)C(C=2C=CC(F)=CC=2)=C1C1=CC=C(F)C=C1 MUTCAPXLKRYEPR-ITWZMISCSA-N 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Natural products C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Abstract
The invention relates to a 2, 3-condensed quinazolinone derivative, a preparation method and application thereof, wherein the 2, 3-quinazolinone derivative is synthesized by a simple method, the yield is high, the production cost is low, when the concentration of LPS is 1 mu m, the release inhibition capability of compounds 1e and 1f is better than that of anti-inflammatory drugs indomethacin and rutaecarpine when the concentration of LPS is 1 mu m, 1g and 1q are equivalent to indomethacin, and 1w and 1m are equivalent to rutaecarpine; the cytoxic effect of the compounds 1e,1f,1g,1q and 1m with stronger NO release inhibiting ability on RAW264.7 cells is lower than that of anti-inflammatory drugs indomethacin and rutaecarpine; has obvious anti-inflammatory effect and low toxicity. Can be prepared into anti-inflammatory medicaments in various dosage forms, and has high medical value and wide market prospect.
Description
Technical Field
The invention relates to the field of pharmaceutical chemistry, in particular to a 2, 3-condensed quinazolinone compound, a preparation method and application thereof.
Background
Quinazolinones are an important class of nitrogen-containing heterocyclic compounds that are widely found in a variety of natural products and drug molecules. Has the functions of anti-inflammatory, anti-tumor, anticonvulsant, tranquilization, depressurization, vasodilation, bacteriostasis and the like, and has great development potential in the pharmaceutical and medical fields. It was found that quinazolinones substituted at both the C2 and N3 positions have anticancer properties. The core structural unit of the quinazolinone derivative contains oxygen atoms and nitrogen atoms, and can also coordinate with metal ions to generate a complex. In addition, the molecular structure of the fluorescent probe is a large conjugated system, has stronger fluorescence performance, and can be used for preparing fluorescent molecular probes. The hydrogen reaction, also called automatic transfer of hydrogen, is a novel organic synthesis method integrating oxidation reaction and hydrogenation reduction reaction. The hydrogen-assisted reaction is derived from a metal-catalyzed dehydrogenation reaction, in which a hydrogen donor molecule with lower reactivity is temporarily converted into an intermediate with higher reactivity (for example, alkane is converted into alkene, alcohol is converted into aldehyde or ketone, and amine is converted into imine) under metal catalysis, and the intermediate with higher reactivity is further reacted to obtain a compound containing double bonds such as c= C, C =n, and then the compound is reduced by metal hydride generated in the dehydrogenation step to generate single bonds such as C-C, C-N respectively. The reaction typically uses an alcohol or amine as the alkylating agent, producing water or ammonia, respectively, as the only by-product. Therefore, from the aspects of chemical synthesis and green environmental protection, the hydrogen-borrowing reaction has the characteristics of high efficiency, green, cleanness and the like, and is widely paid attention to people.
Disclosure of Invention
The invention aims to provide a 2, 3-condensed quinazolinone compound with good anti-inflammatory effect and low toxicity, and a preparation method and application thereof. The main synthesis steps are as follows: reacting isatoic anhydride serving as a raw material with 3-amino-1-propanol and the like to synthesize 3- (3-hydroxypropyl) -2- (1H-indol-2-yl) quinazoline-4 (3H) -ketone, and then reacting with hydrogen in molecules to generate a 2, 3-condensed quinazolinone compound. The synthetic route is shown in figure 1.
The invention also provides application of the 2, 3-condensed quinazolinone compound in preparing anti-inflammatory drugs.
According to the invention, a simple method is used for synthesizing a 2, 3-condensed quinazolinone derivative, when the concentration of LPS is 1 mu g/mL and the concentration of LPS is 5 mu m, the release inhibition capacity of compounds 1e and 1f is better than that of anti-inflammatory drugs indomethacin and rutaecarpine, 1g and 1q are equivalent to that of indomethacin, and 1w and 1m are equivalent to that of rutaecarpine; the cytoxic effect of the compounds 1e,1f,1g,1q and 1m with stronger NO release inhibiting ability on the mouse macrophage RAW264.7 is lower than that of the anti-inflammatory drugs indomethacin and rutaecarpine; the anti-inflammatory effect is obvious, the toxicity is small, and the test results of part of the compounds are shown in figures 2 and 3. The composition can be used for preparing anti-inflammatory medicaments in various dosage forms, and has high medical value and wide market prospect.
The invention has the advantages that:
1. the raw materials selected by the scheme are easy to obtain, and various 2, 3-condensed quinazolinone compounds are easy to prepare.
2. The proposal adopts alcohol as alkylating agent, only produces byproduct water, and has the characteristics of green and high atom economy.
3. The 2, 3-condensed quinazolinone compound synthesized by the scheme has obvious anti-inflammatory effect and low toxicity, and can be used for preparing anti-inflammatory drugs in various dosage forms.
Drawings
FIG. 1 is a reaction scheme for preparing 2, 3-fused quinazolinone compounds of the present invention
FIG. 2 partial Compound action NO Release from RAW264.7 cells
FIG. 3 survival of RAW264.7 cells with partial Compound
Detailed Description
Any feature disclosed in this specification (including any accompanying claims, abstract) may be replaced by alternative features serving the same, equivalent or similar purpose, unless expressly stated otherwise. That is, each feature is one example only of a generic series of equivalent or similar features, unless expressly stated otherwise.
In the embodiments to be described below, 1 the internal standard at the time of H NMR testing was Tetramethylsilane (TMS).
Example 1:
the reaction steps are as follows:
1. synthesis of Compound 1a
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 6-methyl isatoic anhydride 2a (1 mmol,177.2 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at ambient temperature for 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), 110.2. 110.2 mg yellow oily compound 3a (yield 53%).
Under electromagnetic stirring, compound 3a (0.6 mmol,124.3 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) are sequentially added into a 100 mL round bottom flask, after reaction at normal temperature under the protection of nitrogen for 4H, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) is added under the condition of ice water bath, the reaction is carried out again for 0.5H, then the ice water bath is removed for continuous reaction for 4H, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to afford 185 mg as a tan powder compound 4a (93% yield).
Under electromagnetic stirring, compound 4a (0.3 mmol,100 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (Xantphos, 0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N, N-dimethylformamide (2 mL) were added to a vial, the reaction was sealed at 165℃for 24 h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), to give 45.4. 45.4 mg yellow powdery compound 1a (yield 48%). 1 H NMR (500 MHz,DMSO) δ 7.68 (t,J = 8.5 Hz, 3H),7.54 (d,J = 8.5 Hz,1H),7.30 (t,J = 8.0 Hz,2H),7.13 (d,J = 13.0 Hz,2H),4.44 (t,J = 7.0 Hz,2H),4.01 (t,J = 7.0 Hz,2H),2.84 (s,3H),2.31–2.26 (m,2H)。
2. Synthesis of Compound 1b
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 3-methylindole anhydride 2b (1 mmol,177.2 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at ambient temperature for 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 151.6 mg as yellow powder compound 3b (yield 73%).
Under electromagnetic stirring, compound 3b (0.6 mmol,124.3 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) were sequentially added to a 100 mL round bottom flask, after reaction at room temperature under nitrogen protection of 4H, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) was added under ice water bath, the reaction was again carried out for 0.5H, then the ice water bath was removed to continue the reaction for 4H, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 170.8 mg as a brown powder compound 4b (yield 85%).
Under electromagnetic stirring, compound 4b (0.3 mmol,100 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N, N-dimethylformamide (2 mL) were added into a tube-sealed reaction flask, the reaction was sealed at 165℃for 24 h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1) to give 60 mg as yellow powder compound 1b (yield 63%). 1 H NMR (500 MHz,DMSO) δ 8.03 (d,J = 8.0 Hz,1H),7.72–7.66 (m,3H),7.43 (t,J = 7.5 Hz,1H),7.30 (t,J = 7.5 Hz,1H),7.18 (s,1H),7.13 (t,J = 7.5 Hz,1H),4.44 (t,J = 7.0 Hz,2H),4.06 (t,J = 6.5 Hz,2H),2.58 (s,3H),2.32–2.27 (m,2H)。
3. Synthesis of Compound 1c
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 3-methoxyisatoic anhydride 2c (1 mmol,0.1932 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at ambient temperature for 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), giving 207 mg as yellow oily compound 3c (93% yield).
Under electromagnetic stirring, compound 3c (0.6 mmol,133.9 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) were sequentially added to a 100 mL round bottom flask, after reaction at room temperature under nitrogen protection of 4H, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) was added under ice water bath, the reaction was again carried out for 0.5H, then the ice water bath was removed to continue the reaction for 4H, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), to give 184.6 mg as a brown powder compound 4c (yield 88%).
Compound 4c (0.3 mmol, 7. 104.7 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N-dimethylformamide (2 mL) were added in sequence to a tube-sealed reaction flask under electromagnetic stirring, the reaction was sealed at 165 ℃ for 24 h, and the crude product was purified by column chromatography over silica gel (eluent: V Dichloromethane (dichloromethane) : V Petroleum ether =3:1), to give 37.7. 37.7 mg as a tan powder compound 1c (yield 38%). 1 H NMR (500 MHz,DMSO) δ 7.74 (d,J = 8.0 Hz,1H),7.71 (d,J = 8.0 Hz,1H),7.67 (d,J = 8.5 Hz,1H),7.49 (t,J = 8.0 Hz,1H),7.40 (d,J = 8.0 Hz,1H),7.30 (t,J = 7.5 Hz,1H),7.13 (d,J = 6.5 Hz,2H),4.43 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),3.94 (s,3H),2.31–2.26 (m,2H)。
4. Synthesis of Compound 1d
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) are added into a 100 mL round bottom flask in sequence under electromagnetic stirring, 4- (trifluoromethyl) isatoic anhydride 2d (1 mmol,231.1 mg) is slowly added under the ice-water bath condition, the ice-water bath is removed after 30 min, the reaction is carried out at normal temperature 4h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 185.7. 185.7 mg as a white powder compound 3d (yield 71%).
Under electromagnetic stirring, adding 3d (0.6 mmol,157.3 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), to give 188.1. 188.1 mg as a brown powder compound 4d (yield 81%).
Under electromagnetic stirring, adding 4d (0.3 mmol,116.2 mg), ruthenium (0.015 mmol,14.4 mg) tri (triphenylphosphine) chloride, 4, 5-bis (diphenylphosphine) -9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent): V Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 46 mg as a tan powder compound 1d (41% yield). 1 H NMR (500 MHz,DMSO) δ 8.38 (d,J = 8.5 Hz,1H),8.06 (s,1H),7.85 (d,J = 8.5 Hz,1H),7.73–7.68 (m,2H),7.32 (t,J = 7.5 Hz,1H),7.21 (s,1H),7.14 (t,J = 7.5 Hz,1H),4.49 (t,J = 6.5 Hz,2H),4.07 (t,J = 6.5 Hz,2H),2.34–2.29 (m,2H)。
5. Synthesis of Compound 1e
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 5-methylidene anhydride 2e (1 mmol,231.1 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at room temperature for 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 185.7. 185.7 mg as a white powder compound 3e (yield 71%).
Under electromagnetic stirring, sequentially adding 3e (0.6 mmol,157.3 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 188.1. 188.1 mg as brown powder compound 4e (yield 81%).
Compound 4e (0.3 mmol,116.2 mg), ruthenium (0.015 mmol,14.4 mg) tris (triphenylphosphine) chloride, 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) were sequentially stirred electromagneticallyAdding N, N-dimethylformamide (2 mL) into a tube-sealed reaction bottle, sealing at 165 deg.C for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 46 mg as a tan powder compound 1e (41% yield). 1 H NMR (500 MHz,DMSO) δ 8.38 (d,J = 8.5 Hz,1H),8.06 (s,1H),7.85 (d,J = 8.5 Hz,1H),7.73–7.68 (m,2H),7.32 (t,J = 7.5 Hz,1H),7.21 (s,1H),7.14 (t,J = 7.5 Hz,1H),4.49 (t,J = 6.5 Hz,2H),4.07 (t,J = 6.5 Hz,2H),2.34–2.29 (m,2H)。
6. Synthesis of Compound 1f
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 5-methoxyisatoic anhydride 2f (1 mmol, 193.2 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at ambient temperature for 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 188.26 mg as a white powder compound 3f (yield 84%).
Under electromagnetic stirring, sequentially adding 3f (0.6 mmol,133.9 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 129 mg as brown powder compound 4f (yield 72%).
Compound 4f (0.3 mmol,104.7 mg), tris (triphenylphosphine) was sequentially stirred electromagnetically) Ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) are added into a tube-sealing reaction bottle, the reaction is sealed at 165 ℃ for 24 h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 54.6. 54.6 mg as a tan powder compound 1f (55% yield). 1 H NMR (500 MHz,DMSO) δ 7.71–7.65 (m,3H),7.57 (d,J = 3.0 Hz,1H),7.47–7.45 (m,1H),7.29 (t,J = 7.5 Hz,1H),7.14–7.09 (m,2H),4.43 (t,J = 7.0 Hz,2H),4.06 (t,J = 6.5 Hz,2H),3.90 (s,3H),2.31–2.26 (m,2H)。
7. Synthesis of Compound 1g
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) are added into a 100 mL round bottom flask in sequence under electromagnetic stirring, 2g (1 mmol, 181.1 mg) of 5-fluoroisatoic anhydride is slowly added under the ice-water bath condition, the ice-water bath is removed after 30 min, the reaction is carried out at normal temperature for 4h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 161.1. 161.1 mg as yellow powder compound 3g (yield 76%).
Under electromagnetic stirring, 3g (0.6 mmol,127.3 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) are sequentially added into a 100 mL round bottom flask, after reaction at normal temperature under the protection of nitrogen for 4H, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) is added under the ice-water bath condition, the reaction is carried out again for 0.5H, then the ice water bath is removed for continuing the reaction for 4H, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), to give 196.2. 196.2 mg brown powdery compound 4g (yield 97%).
Under electromagnetic stirring, 4g (0.3 mmol,101.1 mg) of the compound, ruthenium (0.015 mmol,14.4 mg) chloride, 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) are added into a tube-sealing reaction bottle in sequence, the mixture is subjected to a sealed reaction at 165 ℃ for 24 h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 56.5. 56.5 mg tan powder compound 1g (yield 59%). 1 H NMR (500 MHz,DMSO) δ 8.13 (s,1H),7.88 (d,J = 8.5 Hz,1H),7.76 (d,J = 8.5 Hz,1H),7.73–7.64 (m,2H),7.31 (t,J = 8.0 Hz,1H),7.18 (s,1H),7.13 (t,J = 7.5 Hz,1H),4.46 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),2.33–2.27 (m,2H)。
8. Synthesis of Compound 1h
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 5-chloroisatoic anhydride (1 mmol,197.6 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at ambient temperature 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 148 mg as yellow crystalline compound 3h (yield 65%).
Under electromagnetic stirring, sequentially adding 3H (0.6 mmol,136.8 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (washingStripping agent V Dichloromethane (dichloromethane) : V Methanol =200:2) to give 192.8 mg as a brown powder compound 4h (91% yield).
Under electromagnetic stirring, adding the compound 4h (0.3 mmol,105.9 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 42.2. 42.2 mg as a tan powder compound 1h (42% yield). 1 H NMR (500 MHz,DMSO) δ 11.07 (s,1H),7.83 (s,1H),7.62 (d,J = 7.0 Hz,1H),7.47 (d,J = 7.5 Hz,1H),7.36 (d,J = 8.0 Hz,1H),7.12 (t,J = 7.5 Hz,1H),7.02 (d,J = 8.0 Hz,2H),6.18 (s,1H),4.70–4.53 (m,1H),3.36 (s,3H),3.24–3.21 (m,1H),2.95 (s, 3H)。
9. Synthesis of Compound 1i
Under electromagnetic stirring, compound 3f (0.6 mmol,136.8 mg), 5-methoxy-1H-indole-2-carbaldehyde (0.9 mmol,157.6 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) are added into a 100 mL round bottom flask, after reaction at normal temperature under the protection of nitrogen gas of 4H, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) is added under the condition of ice water bath, the reaction is carried out again for 0.5H, then the ice water bath is removed for continuous reaction for 4H, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 213 mg as a tan powder compound 4i (94% yield).
Compound 4i (0.3 mmol,113.8 mg), tris (triphenylphosphine) ruthenium chloride (0) was sequentially stirred electromagnetically015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N, N-dimethylformamide (2 mL) were added to a tube-sealed reaction flask, the reaction was sealed at 165℃for 24 h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 35.5. 35.5 mg tan powder compound 1i (33% yield) was obtained. 1 H NMR (500 MHz,DMSO) δ 7.69 (d,J = 9.0 Hz,1H),7.62–7.51 (m,2H),7.47–7.44 (m,1H),7.15 (s,1H),7.02 (s,1H),6.93 (d,J = 9.0 Hz,1H),4.38 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),3.90 (s,3H),3.79 (s,3H),2.30–2.25 (m,2H)。
10. Synthesis of Compound 1j
Under electromagnetic stirring, compound 3e (0.6 mmol,124.9 mg), 5-methoxy-1H-indole-2-carbaldehyde (0.9 mmol,157.6 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) are sequentially added into a 100 mL round bottom flask, after reaction at normal temperature under the protection of nitrogen gas of 4H, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) is added under the ice-water bath condition, the reaction is carried out again for 0.5H, then the ice-water bath is removed for continuous reaction for 4H, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 187.4. 187.4 mg as a tan powder compound 4j (86% yield).
Under electromagnetic stirring, adding the compound 4j (0.3 mmol,108.9 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle in turn, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloro-sMethane : V Petroleum ether =3:1) to give 33 mg as a tan powder compound 1j (33% yield). 1 H NMR (500 MHz,DMSO) δ 7.98 (s,1H),7.67 (d,J = 8.5 Hz,1H),7.63 (d,J = 8.0 Hz,1H),7.58 (d,J = 9.0 Hz,1H),7.16 (s,1H),7.04 (s,1H),6.94 (d,J = 9.0 Hz,1H),4.39 (t,J = 7.0 Hz,2H),4.04 (t,J = 6.5 Hz,2H),3.79 (s,3H),2.48 (s,3H),2.27 (t,J = 6.5 Hz,2H)。
11. Synthesis of Compound 1k
Under electromagnetic stirring, sequentially adding 3f (0.6 mmol,133.9 mg), 6-chloro-1H-indole-2-carbaldehyde (0.9 mmol,161.6 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 202 mg as a tan powder compound 4k (87% yield).
Under electromagnetic stirring, adding the compound 4k (0.3 mmol,108.9 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle in turn, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1) to give 57 mg as a tan powder compound 1k (yield 52%). 1 H NMR (500 MHz,DMSO) δ 7.86 (s,1H),7.69 (d,J = 8.5 Hz,2H),7.57 (d,J = 3.0 Hz,1H),7.47–7.45 (m,1H),7.12 (d,J = 6.5 Hz,2H),4.43 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),3.90 (s,3H),2.30–2.25 (m,2H)。
12. Synthesis of Compound 1l
Under electromagnetic stirring, sequentially adding 3e (0.6 mmol,124.9 mg), 6-chloro-1H-indole-2-carbaldehyde (0.9 mmol,161.6 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), to give 196 mg as a tan powder compound 4l (89% yield).
Under electromagnetic stirring, adding 4l (0.3 mmol,110.1 mg), ruthenium (0.015 mmol,14.4 mg) tri (triphenylphosphine) chloride, 4, 5-bis (diphenylphosphine) -9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), giving 60.7. 60.7 mg as a tan powder compound 1l (58% yield). 1 H NMR (500 MHz,DMSO) δ 7.99 (s,1H),7.87 (s,1H),7.74–7.66 (m,2H),7.64 (d,J = 8.0 Hz,1H),7.19–7.08 (m,2H),4.44 (t,J = 7.0 Hz,2H),4.04(t,J = 6.5 Hz, 2H),2.48(s,3H),2.29–2.25(m,2H)。
13. Synthesis of Compound 1m
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) are added into a 100 mL round bottom flask in sequence under electromagnetic stirring, isatoic anhydride 2m (1 mmol,163 mg) is slowly added under the ice water bath condition, the ice water bath is removed after 30 min, the reaction is carried out at normal temperature 4h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), giving 155.3. 155.3 mg as a white powder compound 3m (88% yield).
Under electromagnetic stirring, adding 3m (0.6 mmol,116.5 mg), 6-chloro-1H-indole-2-carbaldehyde (0.9 mmol,161.6 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), to give 184.3. 184.3 mg as a tan powder compound 4m (yield 87%).
Under electromagnetic stirring, adding 4m (0.3 mmol,105.9 mg), ruthenium (0.015 mmol,14.4 mg) tri (triphenylphosphine) chloride, 4, 5-bis (diphenylphosphine) -9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), to give 61.3. 61.3 mg as a tan powder compound 1m (yield 61%). 1 H NMR (500 MHz,DMSO) δ 7.99 (s,1H),7.87 (s,1H),7.74–7.66 (m,2H),7.64 (d,J = 8.0 Hz,1H),7.19–7.08 (m,2H),4.44 (t,J = 7.0 Hz,2H),4.04 (t,J = 6.5 Hz,2H),2.48 (s,3H),2.29–2.25 (m,2H)。
14. Synthesis of Compound 1n
Under electromagnetic stirring, adding 3m (0.6 mmol,116.5 mg), 6-bromo-1H-indole-2-carbaldehyde (0.9 mmol,200 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at room temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 197.73 mg as a tan powder compound 4n (83% yield).
Under electromagnetic stirring, adding the compound 4N (0.3 mmol,119.1 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle in turn, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 48.9. 48.9 mg tan powder compound 1n (53% yield) was obtained. 1 H NMR (500 MHz,DMSO) δ 8.20 (d,J = 8.0 Hz,1H),8.02 (s,1H),7.86 (t,J = 7.5 Hz,1H),7.74 (d,J = 8.0 Hz,1H),7.66 (d,J = 8.5 Hz,1H),7.57 (t,J = 7.5 Hz,1H),7.25 (d,J = 8.5 Hz,1H),7.18 (s,1H),4.46 (s,2H),4.05 (t,J = 6.5 Hz,2H),2.31–2.27 (m,2H)。
15. Synthesis of Compound 1o
Compound 3e (0.6 mmol,124.9 mg), 5-methyl-1H-indole-2-carbaldehyde (0.9 mmol, 14) was successively stirred electromagnetically3.2 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg), tetrahydrofuran (30 mL) are added into a 100 mL round bottom flask, after 4h reaction at normal temperature under the protection of nitrogen, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) is added under the ice water bath condition, 0.5 h reaction is carried out again, then the ice water bath is removed to continue the reaction for 4h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), giving 183.3. 183.3 mg as a tan powder compound 4o (88% yield).
Under electromagnetic stirring, adding 4o (0.3 mmol,104.1 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 54.3 mg as a tan powder compound 1o (55% yield). 1 H NMR (500 MHz,DMSO) δ 7.98 (s,1H),7.67 (d,J = 8.0 Hz,1H),7.63 (d,J = 8.0 Hz,1H),7.55 (d,J = 8.5 Hz,1H),7.45 (s,1H),7.12 (d,J = 8.5 Hz,1H),7.04 (s,1H),4.39 (t,J = 7.0 Hz,2H),4.03 (t,J = 6.5 Hz,2H),2.48 (s,3H),2.40 (s,3H),2.29–2.24 (m,2H)。
16. Synthesis of Compound 1p
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added to a 100 mL round bottom flask in sequence under electromagnetic stirring, 4-methyl isatoic anhydride 2p (1 mmol,177.2 mg) was slowly added under ice-water bath conditions, the ice-water bath was removed after 30 min, the reaction was performed at room temperature, 4h was performed, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), yielding 176.9 mg whiteCompound 3p was a coloured powder (85% yield).
Under electromagnetic stirring, sequentially adding 3p (0.6 mmol,124.9 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 181.9 mg as a tan powder compound 4p (91% yield).
Under electromagnetic stirring, compound 4p (0.3 mmol,100 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N, N-dimethylformamide (2 mL) were added to a tube-sealed reaction flask, the reaction was sealed at 165℃for 24 h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 38.8. 38.8 mg tan powder compound 1p (41% yield) was obtained. 1 H NMR (500 MHz,DMSO) δ 8.08 (d,J = 8.0 Hz,1H),7.71–7.67 (m,2H),7.55 (s,1H),7.39 (d,J = 8.0 Hz,1H),7.30 (t,J = 7.5 Hz,1H),7.14 (d,J = 9.5 Hz,2H),4.44 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),2.49 (s,3H),2.32–2.26 (m,2H)。
17. Synthesis of Compound 1q
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 mmol,0.2 mL) were added sequentially to a 100 mL round bottom flask under electromagnetic stirring, 4-chloroisatoic anhydride 2q (1 mmol,197 mg) was slowly added under ice water bath conditions, the ice water bath was removed after 30 min,normal temperature reaction 4h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3) to give 187 mg as a white powder compound 3q (yield 82%).
Under electromagnetic stirring, sequentially adding 3q (0.6 mmol,136.8 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round-bottomed flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 197 mg as a tan powder compound 4q (93% yield).
Under electromagnetic stirring, adding 4q (0.3 mmol,106 mg), ruthenium (0.015 mmol,14.4 mg) tri (triphenylphosphine) chloride, 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealed reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), to give 49.4. 49.4 mg as a tan powder compound 1q (yield 49%). 1 H NMR (500 MHz,DMSO) δ 8.17 (d,J = 8.5 Hz,1H),7.78 (d,J = 2.0 Hz,1H),7.71–7.67 (m,2H),7.59–7.56 (m,1H),7.31 (t,J = 7.5 Hz,1H),7.18 (s,1H),7.13 (t,J = 7.5 Hz,1H),4.46 (t,J = 7.0 Hz,2H),4.04 (t,J = 6.5 Hz,2H),2.29 (t,J = 6.5 Hz,2H)。
18. Synthesis of Compound 1r
Acetonitrile (30 mL), 3-amino-1-propanol (1.5 m) were sequentially stirred electromagneticallymol, 0.2. 0.2 mL) was added to a 100 mL round bottom flask, 4-methoxyisatoic anhydride 2r (1 mmol,193 mg) was slowly added under ice water bath conditions, the ice water bath was removed after 30 min, the reaction was performed at ambient temperature 4h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:3), to give 197 mg as a white powder compound 3r (yield 88%).
Under electromagnetic stirring, sequentially adding 3r (0.6 mmol,134.5 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 169.7. 169.7 mg as a tan powder compound 4r (yield 81%).
Under electromagnetic stirring, adding the compound 4r (0.3 mmol,105 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealed reaction bottle in sequence, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), giving 37.7. 37.7 mg as a tan powder compound 1r (38% yield). 1 H NMR (500 MHz,DMSO) δ 8.10 (t,J = 10.0 Hz,1H),7.73–7.67 (m,2H),7.30 (t,J = 8.0 Hz,1H),7.21–7.09 (m,4H),4.44 (t,J = 8.5 Hz,2H),4.03 (t,J = 8.5 Hz,2H),3.96–3.88 (m,3H),2.33–2.23 (m,2H)。
19. Synthesis of Compound 1s
Under electromagnetic stirring, adding 3m (0.6 mmol,116.5 mg), 4-methoxy-1H-indole-2-carbaldehyde (0.9 mmol,157.7 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition after reacting at normal temperature of 4H, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 190.63 mg as a tan powder compound 4s (91% yield).
Under electromagnetic stirring, adding the compound 4s (0.3 mmol,104.7 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle in turn, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 54.6. 54.6 mg as a tan powder compound 1s (yield 55%). 1 H NMR (500 MHz,DMSO) δ 8.20 (d,J = 8.0 Hz,1H),8.02 (s,1H),7.86 (t,J = 7.5 Hz,1H),7.74 (d,J = 8.0 Hz,1H),7.66 (d,J = 8.5 Hz,1H),7.57 (t,J = 7.5 Hz,1H),7.25 (d,J = 8.5 Hz,1H),7.18 (s,1H),4.46 (s,2H),4.05 (t,J = 6.5 Hz,2H),2.31–2.27 (m,2H)。
20. Synthesis of Compound 1t
Compound 3m (0.6 mmol,116.5 mg), 5-methoxy-1H-indole-2-carbaldehyde (0.9 mmol,157.7 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg), tetrahydrofuran (3)0.0 mL) is added into a 100 mL round bottom flask, after 4h of normal temperature reaction under the protection of nitrogen, 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) is added under the ice-water bath condition to react again with 0.5 h, then the ice-water bath is removed to continue the reaction for 4h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2) to give 196.92 mg as a tan powder compound 4t (94% yield).
Under electromagnetic stirring, adding the compound 4t (0.3 mmol,104.7 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle in sequence, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), to give 51.7. 51.7 mg as a tan powder compound 1t (yield 52%). 1 H NMR (500 MHz,DMSO) δ 8.19 (d,J = 8.0 Hz,1H),7.85 (t,J = 7.5 Hz,1H),7.73 (d,J = 8.0 Hz,1H),7.59–7.54 (m,2H),7.17 (s,1H),7.07 (s,1H),6.95 (d,J = 9.0 Hz,1H),4.41 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),3.79 (s,3H),2.31–2.26 (m,2H)。
21. Synthesis of Compound 1u
Under electromagnetic stirring, sequentially adding 3m (0.6 mmol,116.5 mg), 5-chloro-1H-indole-2-carbaldehyde (0.9 mmol,161.1 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), 182.2. 182.2 mg as a tan powder compound 4u (86% yield).
Under electromagnetic stirring, adding 4u (0.3 mmol,105.9 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyl xanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg) and N, N-dimethylformamide (2 mL) into a tube-sealing reaction bottle, sealing at 165 ℃ for reaction 24 h, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 58.3 mg as a tan powder compound 1u (58% yield). 1 H NMR (500 MHz,DMSO) δ 8.19 (d,J = 8.0 Hz,1H),7.86 (t,J = 7.5 Hz,1H),7.80–7.68 (m,3H),7.57 (t,J = 7.5 Hz,1H),7.30 (d,J = 9.0 Hz,1H),7.15 (s,1H),4.46 (t,J = 7.0 Hz,2H),4.05 (t,J = 6.5 Hz,2H),2.31–2.26 (m,2H)。
22. Synthesis of Compound 1v
Under electromagnetic stirring, sequentially adding 3m (0.6 mmol,116.5 mg), 5-methyl-1H-indole-2-carbaldehyde (0.9 mmol,143.2 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuing to react for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), giving 178 mg as a tan powder compound 4v (89% yield).
Under electromagnetic stirring, compound 4v (0.3 mmol,100 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethyloxaAnthracene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N, N-dimethylformamide (2 mL) are added into a tube-sealed reaction flask, the reaction is sealed at 165 ℃ for 24 h, and the crude product is purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 49.2. 49.2 mg tan powder compound 1v (yield 52%). 1 H NMR (500 MHz,DMSO) δ 8.19 (d,J = 8.0 Hz,1H),7.85 (t,J = 7.5 Hz,1H),7.73 (d,J = 8.0 Hz,1H),7.56 (d,J = 7.5 Hz,2H),7.47 (s,1H),7.13 (d,J = 8.5 Hz,1H),7.07 (s,1H),4.41 (t,J = 7.0 Hz,2H),4.04 (t,J = 6.5 Hz,2H),2.40 (s,3H),2.30–2.25 (m,2H)。
22. Synthesis of Compound 1w
Under electromagnetic stirring, sequentially adding 3m (0.6 mmol,116.5 mg), 1H-indole-2-carbaldehyde (0.9 mmol,130.5 mg), anhydrous magnesium sulfate (1.32 mmol,158.9 mg), paratoluenesulfonic acid hydrate (0.12 mmol,22.8 mg) and tetrahydrofuran (30 mL) into a 100 mL round bottom flask, reacting at normal temperature under nitrogen protection for 4H, adding 2, 3-dichloro-5, 6-dicyanobenzoquinone (0.48 mmol,108.9 mg) under ice water bath condition, reacting again for 0.5H, removing ice water bath, continuously reacting for 4H, purifying the crude product by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Methanol =200:2), giving 172 mg as a tan powder compound 4w (80% yield).
Under electromagnetic stirring, compound 4w (0.3 mmol,95.7 mg), tris (triphenylphosphine) ruthenium chloride (0.015 mmol,14.4 mg), 4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (0.03 mmol,17.4 mg), cesium carbonate (0.6 mmol,195.5 mg), N, N-dimethylformamide (2 mL) were added to a tube-sealed reaction flask, the reaction was sealed at 165℃for 24 h, and the crude product was purified by silica gel column chromatography (eluent: V) Dichloromethane (dichloromethane) : V Petroleum ether =3:1), 53 is obtainedmg of compound 1w as a tan powder (59% yield). 1 H NMR (500 MHz,DMSO) δ 8.20 (d,J = 6.5 Hz,1H),7.86 (t,J = 7.0 Hz,1H),7.74 (d,J = 8.0 Hz,1H),7.67–7.71 (m,2H),7.56 (t,J = 7.5 Hz,1H),7.30 (t,J = 8.0 Hz,1H),7.17 (s,1H),7.13 (t,J = 7.5 Hz,1H),4.45 (t,J = 7.0 Hz,2H),4.06 (t,J = 6.5 Hz,2H),2.30 (t,J = 6.5 Hz,2H)。
Part of the above target products were tested for anti-inflammatory activity. Anti-inflammatory activity was determined by determining the inhibition of Lipopolysaccharide (LPS) -induced release of mouse macrophage RAW264.7 NO by the compound using the Griess method. The results of the experiment for inhibiting lipopolysaccharide-induced release of NO by mouse macrophage RAW264.7 with a part of the target compounds are shown in Table 1. The effect of the target compound on RAW264.7 cell viability at a concentration of 5 μm is shown in table 2.
TABLE 1
TABLE 2
From the above test results, when the concentration of LPS is 1 μg/mL, the release inhibition ability of the compounds 1e and 1f is better than that of the anti-inflammatory drugs indomethacin and rutaecarpine, while 1g and 1q are equivalent to that of indomethacin and 1w and 1m are equivalent to rutaecarpine; the cytoxic effect of the compounds 1e,1f,1g,1q and 1m with stronger NO release inhibiting ability on RAW264.7 cells is lower than that of anti-inflammatory drugs indomethacin and rutaecarpine; has obvious anti-inflammatory effect and low toxicity.
While the invention has been described in detail in the foregoing general description and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that modifications and improvements can be made thereto. Accordingly, such modifications or improvements may be made without departing from the spirit of the invention and are intended to be within the scope of the invention as claimed.
Claims (5)
1. A2, 3-condensed quinazolinone compound is characterized in that the C2 and N3 positions of the compound on quinazolinone are simultaneously substituted, and the structural general formula is as follows:wherein R is 1 Or R is 2 Can be H, methoxy, ethoxy, methyl, ethyl, phenyl, benzyl, nitro, fluorine, chlorine, bromine, trifluoromethyl and difluoromethyl.
2.2, 3-fused quinazolinone compound according to claim 1, characterized in that R 1 Or R is 2 Can be H, methoxy, ethoxy, methyl, ethyl, fluoro, chloro, bromo, trifluoromethyl.
3.2, 3-fused quinazolinone compound according to claim 1, characterized in that R 1 Can be H, methoxy, methyl, fluorine, chlorine, trifluoromethyl; r is R 2 Can be H, methoxy, methyl, chlorine and bromine.
4. A process for the preparation of a 2, 3-fused quinazolinone compound according to any of claims 1-3, characterized by the specific steps of:
(1) Isatoic anhydride is used as a raw material to react with 1-amino-3-propanol to generate 2-amino-N- (3-hydroxypropyl) benzamide, and the molecular structural formula is as follows:wherein R is 1 =h, methoxy, ethoxy, methyl, ethyl, phenyl, benzyl, nitro, fluoro, chloro, bromo, trifluoromethyl, difluoromethyl;
(2) Reacting the 2-amino-N- (3-hydroxypropyl) benzamide prepared in step (1) with 1H-indole-2-carbaldehyde to produce 3- (3-hydroxypropyl) -2- (1H-indol-2-yl) quinazolin-4 (3H) schemeA ketone having the molecular structural formula:wherein R is 1 = R 2 =h, methoxy, ethoxy, methyl, ethyl, phenyl, benzyl, nitro, fluoro, chloro, bromo, trifluoromethyl, difluoromethyl;
(3) Catalyzing the 3- (3-hydroxypropyl) -2- (1H-indol-2-yl) quinazolin-4 (3H) -one prepared in step (2) with tris (triphenylphosphine) ruthenium chloride to produce a 2, 3-fused quinazolinone compound having the following molecular structural formula:wherein R is 1 = R 2 =h, methoxy, ethoxy, methyl, ethyl, phenyl, benzyl, nitro, fluoro, chloro, bromo, trifluoromethyl, difluoromethyl.
5. Use of a 2, 3-fused quinazolinone compound according to any of claims 1-3 for the preparation of an anti-inflammatory agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311796863.XA CN117800977A (en) | 2023-12-25 | 2023-12-25 | Preparation method and application of 2, 3-condensed quinazolinone compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311796863.XA CN117800977A (en) | 2023-12-25 | 2023-12-25 | Preparation method and application of 2, 3-condensed quinazolinone compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117800977A true CN117800977A (en) | 2024-04-02 |
Family
ID=90424756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311796863.XA Pending CN117800977A (en) | 2023-12-25 | 2023-12-25 | Preparation method and application of 2, 3-condensed quinazolinone compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117800977A (en) |
-
2023
- 2023-12-25 CN CN202311796863.XA patent/CN117800977A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015044844A (en) | Polymorph of eltrombopag and eltrombopag salt and manufacturing method thereof | |
CN101621998B (en) | Benzimidazole cannabinoid agonists bearing substituted heterocyclic group | |
FI59799B (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV 6,7-DIMETOXY-4-AMINO-2- (4- (2-FUROYL) -PIPERAZIN-1-YL) -QUINAZOLINE FOER ANVAENDNING SOM ETT ANTIHYPERTENSIVT MEDEL | |
NZ519692A (en) | Phenylpiperazinyl, -piperidinyl or -tetrahydropyridinyl derivatives | |
ZA200410057B (en) | 1-Ä(Indol-3-yl) carbonylÜpiperazine derivatives. | |
CN114634482B (en) | Diazonium difluoro methylation reagent and synthetic method and application thereof | |
TW200300088A (en) | Piperazine derivatives having ssti antagonistic activity | |
CN112812068B (en) | Alpha-amino alkylation method for C3 site of quinoxalinone | |
CN106187897B (en) | Synthesis method of fused ring pyrazole compound | |
CN117800977A (en) | Preparation method and application of 2, 3-condensed quinazolinone compound | |
CA2474848A1 (en) | Novel tyloindicines and related processes, pharmaceutical compositions and methods | |
EP2348020A1 (en) | Preparation process of erlotinib | |
CN109651367A (en) | A method of preparing 1,4- dihydroquinoline and pyrrolo- [1,2-a] quinolines | |
CN113336703B (en) | Synthesis of 1,3,4, 5-tetrasubstituted 1H-pyrazole derivatives | |
CN100522965C (en) | 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method | |
EP4215521A1 (en) | Fused ring diimide derivative, preparation method therefor and use thereof | |
EP1403251B1 (en) | Bis(2-aryl-5-pyridyl) derivative | |
CN117800978A (en) | Evodiamine analogue, and preparation method and application thereof | |
Liu et al. | Synthesis, crystal structure and biological activity of 5-(4-fluorophenyl)-N, N-dimethyl-7-(trifluoromethyl) pyrazolo [1, 5-a] pyrimidine-3-carboxamide | |
CN113563255A (en) | Preparation method of Rifloxacin intermediate | |
NZ522274A (en) | New polycyclic indanylimidazoles with alpha2 adrenergic activity | |
CN114920684B (en) | Selenium-containing benzamide compound and synthetic method and application thereof | |
CN113278007B (en) | Synthetic method of 2-hydroxy-indole-3-ketone compound | |
AU761122B2 (en) | Aryl-(4-flouro-4-((2-pyridin-2-yl-ethylamino)-methyl)- piperidin-1-yl)-methanone derivatives as 5-HT1 receptor antagonists | |
CN111808072B (en) | Synthetic method of 3-formyl indole derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |